NCT00004763View on ClinicalTrials.gov

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 1993

Conditions
Hyperandrogenism
Interventions
DRUG

leuprolide

DRUG

Ethinyl estradiol/norethindrone

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004763 - Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism | Biotech Hunter | Biotech Hunter